keyword
https://read.qxmd.com/read/38196644/urinary-cell-gene-signature-of-acute-rejection-in-kidney-allografts
#21
Thalia Salinas, Carol Li, Catherine Snopkowski, Vijay K Sharma, Darshana M Dadhania, Karsten Suhre, Thangamani Muthukumar, Manikkam Suthanthiran
INTRODUCTION: A kidney allograft biopsy may display acute T cell-mediated rejection (TCMR), antibody-mediated rejection (ABMR), or concurrent TCMR + ABMR (MR). Development of noninvasive biomarkers diagnostic of all three types of acute rejection is a useful addition to the diagnostic armamentarium. METHODS: We developed customized RT-qPCR assays and measured urinary cell mRNA copy number in 145 biopsy-matched urine samples from 126 kidney allograft recipients and calculated urinary cell three-gene signature score from log 10 -transformed values for the 18S-normalized CD3E mRNA, 18S-normalized CXCL10 mRNA and 18S rRNA...
December 19, 2023: medRxiv
https://read.qxmd.com/read/38176596/traditional-chinese-medicine-residue-enzymatic-hydrolysates-for-production-of-polyhydroxyalkanoate-by-newly-isolated-bacillus-altitudinis
#22
JOURNAL ARTICLE
Xinyue Li, Jing Chen, Yahui Liu, Shuangqing Fu, Peixun Zhang, Na Zhang, Wei Li, Honglei Zhang
Traditional Chinese medicine residue (TCMR) was utilized as an inexpensive carbon source for the production of poly(3-hydroxybutyrate) (PHB) using the newly isolated Bacillus altitudinis HBU-SI7. The results showed that Yu Ping Feng TCMR could be directly hydrolysed by cellulase to obtain a high proportion of glucose (99 % of total sugar) without pretreatment, achieving an enzymatic hydrolysis rate of up to 89.2 %. B. altitudinis could grow and produce PHB when using enzymatically hydrolysed TCMR in a 5-L fermenter...
January 2, 2024: Bioresource Technology
https://read.qxmd.com/read/38150492/distinct-molecular-processes-mediate-donor-derived-cell-free-dna-release-from-kidney-transplants-in-different-disease-states
#23
JOURNAL ARTICLE
Patrick T Gauthier, Katelynn S Madill-Thomsen, Zachary Demko, Adam Prewett, Philippe Gauthier, Philip F Halloran
BACKGROUND: Among all biopsies in the Trifecta-Kidney Study (ClinicalTrials.gov NCT04239703), elevated plasma donor-derived cell-free DNA (dd-cfDNA) correlated most strongly with molecular antibody-mediated rejection (AMR) but was also elevated in other states: T cell-mediated rejection (TCMR), acute kidney injury (AKI), and some apparently normal biopsies. The present study aimed to define the molecular correlates of plasma dd-cfDNA within specific states. METHODS: Dd-cfDNA was measured by the Prospera test...
December 27, 2023: Transplantation
https://read.qxmd.com/read/38137602/indoleamine-2-3-dioxygenase-1-ido1-in-kidney-transplantation-a-guardian-against-rejection
#24
JOURNAL ARTICLE
Krzysztof Wiśnicki, Piotr Donizy, Agnieszka Hałoń, Patryk Wawrzonkowski, Dariusz Janczak, Magdalena Krajewska, Mirosław Banasik
Kidney transplantation is a crucial treatment for end-stage kidney disease, with immunosuppressive drugs helping to reduce acute rejection rates. However, kidney graft longevity remains a concern. This study explores the role of indoleamine 2,3-dioxygenase 1 (IDO1) in kidney transplant immunology. IDO1 breaks down tryptophan, affecting immune cell behavior, primarily T-cells. The research focuses on both cellular and antibody-mediated immune responses, often causing graft damage. The study assessed IDO1 expression in renal transplant biopsies from patients with graft function decline, examining its connection to clinical parameters...
December 6, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38126208/immune-landscape-of-the-kidney-allograft-in-response-to-rejection
#25
JOURNAL ARTICLE
Harsimar Kaur Ahuja, Shafquat Azim, Daniel Maluf, Valeria R Mas
Preventing kidney graft dysfunction and rejection is a critical step in addressing the nationwide organ shortage and improving patient outcomes. While kidney transplants (KT) are performed more frequently, the overall number of patients on the waitlist consistently exceeds organ availability. Despite improved short-term outcomes in KT, comparable progress in long-term allograft survival has not been achieved. Major cause of graft loss at 5 years post-KT is chronic allograft dysfunction (CAD) characterized by interstitial fibrosis and tubular atrophy (IFTA)...
December 22, 2023: Clinical Science (1979-)
https://read.qxmd.com/read/38097016/identification-of-liver-transplant-biopsy-phenotypes-associated-with-distinct-liver-biological-markers-and-allograft-survival
#26
JOURNAL ARTICLE
Zeynep Demir, Marc Raynaud, Olivier Aubert, Dominique Debray, Mylène Sebagh, Jean-Paul Duong Van Huyen, Arnaud Del Bello, Nicolas Congy Jolivet, Valérie Paradis, François Durand, Sophie Muratot, Cécile Lozach, Christophe Chardot, Claire Francoz, Sabine Sarnacki, Audrey Coilly, Didier Samuel, Eric Vibert, Cyrille Féray, Carmen Lefaucheur, Alexandre Loupy
The intricate association between histological lesions and circulating anti-HLA donor-specific antibodies (DSA) in liver transplantation (LT) requires further clarification. We conducted a probabilistic unsupervised approach in a comprehensively well-annotated LT cohort to identify clinically relevant archetypes. We evaluated 490 pairs of LT biopsies with DSA testing from 325 recipients transplanted between 2010-2020 across three French centers, and an external cohort of 202 biopsies from 128 recipients. Unsupervised archetypal analysis integrated all clinico-immuno-histological parameters of each biopsy to identify biopsy archetypes...
December 12, 2023: American Journal of Transplantation
https://read.qxmd.com/read/38092179/development-and-validation-of-a-multi-class-model-defining-molecular-archetypes-of-kidney-transplant-rejection-a-large-cohort-study-of-the-banff-human-organ-transplant-gene-expression-panel
#27
JOURNAL ARTICLE
Hao Zhang, Randy S Haun, Francois Collin, Clarissa Cassol, Johnathan O H Napier, Jon Wilson, Samar Hassen, Kerime Ararat, Christie Boils, Nidia Messias, Tiffany N Caza, L Nicholas Cossey, Shree Sharma, Josephine M Ambruzs, Nikhil Agrawal, Grigoriy Shekhtman, Wenlan Tian, Titte Srinivas, Kunbin Qu, Robert N Woodward, Christopher P Larsen, Steven Stone, Shana M Coley
Gene expression profiling (GEP) from formalin-fixed paraffin-embedded (FFPE) renal allograft biopsies is a promising approach for feasibly providing a molecular diagnosis of rejection. However, large-scale studies evaluating the performance of models using NanoString platform data to define molecular archetypes of rejection are lacking. We tested a diverse retrospective cohort of over 1400 FFPE biopsy specimens, rescored according to Banff 2019 criteria and representing ten of 11 UNOS regions, using the Banff Human Organ Transplant (B-HOT) panel from NanoString and developed a multi-class model from the gene expression data to assign relative probabilities of four molecular archetypes: No Rejection, Antibody-Mediated Rejection (ABMR), T cell-Mediated Rejection (TCMR), and Mixed Rejection...
December 11, 2023: Laboratory Investigation; a Journal of Technical Methods and Pathology
https://read.qxmd.com/read/38042442/molecular-states-associated-with-dysfunction-and-graft-loss-in-heart-transplants
#28
JOURNAL ARTICLE
Philip F Halloran, Katelynn Madill-Thomsen, Martina Mackova, Arezu Z Aliabadi-Zuckermann, Martin Cadeiras, Marisa G Crespo-Leiro, Eugene C Depasquale, Mario Deng, Johannes Gökler, Shelley A Hall, Daniel H Kim, Jon Kobashigawa, Peter Macdonald, Luciano Potena, Keyur Shah, Josef Stehlik, Andreas Zuckermann, Jeff Reeve
PURPOSE: We explored the changes in gene expression correlating with dysfunction and graft failure in endomyocardial biopsies (EMBs). METHODS: Genome-wide microarrays (19462 genes) were used to define mRNA changes correlating with dysfunction (LVEF≤55) and risk of graft loss within 3 years post biopsy. LVEF data was available for 1013 biopsies, and survival data for 779 patients (74 losses). Molecular classifiers were built for predicting dysfunction (LVEF≤55) and post-biopsy 3-year survival...
November 30, 2023: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38040290/transcriptomic-signatures-of-chronic-active-antibody-mediated-rejection-deciphered-by-rna-sequencing-of-human-kidney-allografts
#29
JOURNAL ARTICLE
Yajas Shah, Hua Yang, Franco B Mueller, Carol Li, Shab E Gul Rahim, Elly Varma, Thalia Salinas, Darshana M Dadhania, Steven Salvatore, Surya V Seshan, Vijay K Sharma, Olivier Elemento, Manikkam Suthanthiran, Thangamani Muthukumar
Natural killer (NK) cells mediate spontaneous cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. This dual functionality could enable their participation in chronic active antibody-mediated rejection (CA-ABMR). Earlier microarray profiling studies have not subcategorized antibody-mediated rejection into CA-ABMR and active-ABMR, and the gene expression pattern of CA-ABMR has not been compared with that of T cell-mediated rejection (TCMR). To fill these gaps, we RNA sequenced human kidney allograft biopsies categorized as CA-ABMR, active-ABMR, TCMR, or No Rejection (NR)...
November 29, 2023: Kidney International
https://read.qxmd.com/read/38020751/donor-derived-cell-free-dna-dd-cfdna-in-kidney-transplant-recipients-with-indication-biopsy-results-of-a-prospective-single-center-trial
#30
JOURNAL ARTICLE
Louise Benning, Christian Morath, Annette Fink, Markus Rudek, Claudius Speer, Florian Kälble, Christian Nusshag, Jörg Beimler, Constantin Schwab, Rüdiger Waldherr, Martin Zeier, Caner Süsal, Thuong Hien Tran
Donor-derived cell-free DNA (dd-cfDNA) identifies allograft injury and discriminates active rejection from no rejection. In this prospective study, 106 kidney transplant recipients with 108 clinically indicated biopsies were enrolled at Heidelberg University Hospital between November 2020 and December 2022 to validate the clinical value of dd-cfDNA in a cohort of German patients. dd-cfDNA was quantified at biopsy and correlated to histopathology. Additionally, dd-cfDNA was determined on days 7, 30, and 90 post-biopsy and analyzed for potential use to monitor response to anti-rejection treatment...
2023: Transplant International
https://read.qxmd.com/read/37906981/tissue-mirna-profile-is-associated-with-acute-tubular-necrosis-rejection-phenotypes-and-bk-polyomavirus-associated-nephropathy-in-human-kidney-allografts
#31
JOURNAL ARTICLE
Neva Bezeljak, Nika Kojc, Zeljka Veceric Haler, Miha Arnol, Emanuela Boštjančič
INTRODUCTION: MicroRNAs, short noncoding RNAs, are involved in the modulation of gene expression, mainly by inhibiting the translation of mRNAs. Under physiological conditions, miRNAs are involved in viral infections and immune responses, among others; aberrant miRNA expression has been associated with kidney transplant pathologies, but a comprehensive comparison of later, particularly in tissue sections, is still pending. METHODS: We used the genome-wide screening of miRNAs to identify those potentially involved in the disease processes after kidney transplantation...
October 31, 2023: Nephron
https://read.qxmd.com/read/37901296/assessment-of-donor-derived-cell-free-dna-dd-cfdna-at-surveillance-and-at-clinical-suspicion-of-acute-rejection-in-renal-transplantation
#32
JOURNAL ARTICLE
Evangelos Mantios, Vassilis Filiopoulos, Pantelis Constantoulakis, George Liapis, Angeliki Vittoraki, Silvia Casas, Smaragdi Marinaki, John N Boletis
In our prospective, unicenter cohort study, we collected blood samples from 30 newly kidney transplanted patients, at month 1, 2, 3, and 5 for dd-cfDNA analysis, along with creatinine/eGFR and DSA monitoring, and from 32 patients who underwent an indication biopsy and whose dd-cfDNA levels were measured at the time of biopsy and 1 month afterwards. Fourteen of 32 (43.8%) patients in the biopsy group were diagnosed with TCMR and 5 of 32 (15.6%) with ABMR. Dd-cfDNA proved to be better than creatinine in diagnosing rejection from non-rejection in patients who were biopsied...
2023: Transplant International
https://read.qxmd.com/read/37871799/banff-2022-pancreas-transplantation-multidisciplinary-report-refinement-of-guidelines-for-t-cell-mediated-rejection-antibody-mediated-rejection-and-islet-pathology-assessment-of-duodenal-cuff-biopsies-and-noninvasive-diagnostic-methods
#33
JOURNAL ARTICLE
Cinthia B Drachenberg, Maike Buettner-Herold, Pedro Ventura Aguiar, Catherine Horsfield, Alexei V Mikhailov, John C Papadimitriou, Surya V Seshan, Marcelo Perosa, Ugo Boggi, Pablo Uva, Michael Rickels, Krzyztof Grzyb, Lois Arend, Miriam Cuatrecasas, Maria Fernanda Toniolo, Alton B Farris, Karine Renaudin, Lizhi Zhang, Candice Roufousse, Angelika Gruessner, Rainer Gruessner, Raja Kandaswamy, Steven White, George Burke, Diego Cantarovich, Ronald F Parsons, Matthew Cooper, Yogish C Kudva, Aleksandra Kukla, Abdolreza Haririan, Sandesh Parajuli, Juan Francisco Merino-Torres, Maria Argente-Pla, Raphael Meier, Ty Dunn, Richard Ugarte, Joseph Sushil Rao, Fabio Vistoli, Robert Stratta, Jon Odorico
The Banff pancreas working schema for diagnosis and grading of rejection is widely used for treatment guidance and risk stratification in centers that perform pancreas allograft biopsies. Since the last update, various studies have provided additional insight regarding the application of the schema and enhanced our understanding of additional clinicopathologic entities. This update aims to clarify terminology and lesion description for T cell-mediated and antibody-mediated allograft rejections, in both active and chronic forms...
March 2024: American Journal of Transplantation
https://read.qxmd.com/read/37847714/a-study-on-the-mode-choice-of-large-scale-households-farmland-transfer-in-in-rural-china-based-on-the-economic-analysis-paradigm-of-transaction-costs
#34
JOURNAL ARTICLE
Guoping He, Taofen Xiao
Regarding the mode choice of farmland transfer, the existing literature have more examined the choices between market-based transfer (spontaneous transfer) and government or village committee-led transfer, and between formal contract and informal contract. However, the question that how the two parties choose among various specific transfer modes has not attracted extensive attention of scholars. Based on contract theory and transaction cost economics, this paper uses the public samples of the third national agricultural census data to investigate how large-scale households choose among the specific transfer modes when transferring into farmland, like the transfer of the contracted management right (TCMR), lease and shareholding...
2023: PloS One
https://read.qxmd.com/read/37781552/donor-derived-cell-free-dna-and-active-rejection-in-renal-allografts
#35
JOURNAL ARTICLE
Edwin Fernando, Harshavardhan Trichy Sanathkumar, Aravind Ramanathan, N D Srinivasaprasad, K Thirumalvalavan, Poongodi Annadurai, S Sujith
BACKGROUND: Renal allograft rejection contributes to significant morbidity and graft loss. In this setting, early detection of rejection is of paramount importance, which currently relies on histopathology. A reliable non-invasive marker to predict rejection would make surveillance and decision-making easier. Donor-derived cell-free DNA (dd-Cf-DNA) has recently been reported as an emerging tool to predict rejection noninvasively. The utility of cell-free DNA in clinical practice has so far not been studied in an Indian setting...
2023: Indian Journal of Nephrology
https://read.qxmd.com/read/37762119/discrepancy-analysis-between-histology-and-molecular-diagnoses-in-kidney-allograft-biopsies-a-single-center-experience
#36
JOURNAL ARTICLE
Liye Suo, Martha Caicedo Murillo, Brian Gallay, Reut Hod-Dvorai
Histology diagnosis is essential for the monitoring and management of kidney transplant patients. Nowadays, the accuracy and reproducibility of histology have been criticized when compared with molecular microscopy diagnostic system (MMDx). Our cohort included 95 renal allograft biopsies with both histology and molecular diagnoses. Discrepancies between histology and molecular diagnosis were assessed for each biopsy. Among the 95 kidney allograft biopsies, a total of 6 cases (6%) showed clear ( n = 4) or borderline ( n = 2) discrepancies between histology and molecular diagnoses...
September 7, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37755331/roles-of-interferon-regulatory-factor-4-in-the-aki-ckd-transition-glomerular-diseases-and-kidney-allograft-rejection
#37
REVIEW
Jianling Song, Ben Ke, Weiping Tu, Xiangdong Fang
Interferon regulatory factor 4 (IRF4) is expressed in immune cells and is a member of the interferon regulatory factor family. Recently, it has been found that IRF4 plays important roles in the acute kidney injury (AKI)-chronic kidney disease (CKD) transition, glomerular diseases and kidney allograft rejection. In particular, the relationship between IRF4 and the AKI-CKD transition has attracted widespread attention. Furthermore, it was also found that the deficiency of IRF4 hindered the transition from AKI to CKD through the suppression of macrophage-to-fibroblast conversion, inhibition of M1-M2 macrophage polarization, and reduction in neutrophil inward flow...
2023: Renal Failure
https://read.qxmd.com/read/37750353/follow-up-biopsies-identify-high-rates-of-persistent-rejection-in%C3%A2-pediatric-kidney-transplant-recipients-after-treatment-of-t-cell-mediated-rejection
#38
JOURNAL ARTICLE
Adina Landsberg, S Sikandar Raza, Michael E Seifert, Tom D Blydt-Hansen
BACKGROUND: Incomplete resolution of T cell-mediated rejection (TCMR) after treatment may not be detected with serum creatinine monitoring and is associated with donor-specific antibodies and chronic rejection. We evaluate the utility of follow-up biopsies (FUB) to identify and characterize rates of persistent TCMR after treatment in pediatric kidney transplant patients. METHODS: Patients from two pediatric transplant centers performing standard of care FUB at 1...
September 26, 2023: Pediatric Transplantation
https://read.qxmd.com/read/37730189/relationship-between-blood-and-tissue-based-rejection-related-transcripts-in-heart-transplantation
#39
JOURNAL ARTICLE
Dae Hyun Lee, Ahsan Usmani, Vani Ravichandran, Tammi Wicks, Robby Wu, Theresa Wolf-Doty, Ioana Dumitru, Peter Berman, Guilherme H Oliveira, Benjamin Mackie
PURPOSE: The purpose of the study is to investigate the relationship between blood and tissue-derived rejection-related transcripts from blood gene expression profiling (GEP) and molecular microscope in the setting of allograft rejection in heart transplant. METHODS: All heart transplant patients from August 2021 to May 2022 with both circulating blood GEP (AlloMap; CareDx) and endomyocardial biopsy with molecular microscope diagnostic system (MMDx, One Lambda) within 4 weeks were included (N=173 samples)...
September 18, 2023: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/37726883/using-regression-equations-to-enhance-interpretation-of-histology-lesions-of-kidney-transplant-rejection
#40
JOURNAL ARTICLE
Majid L N Sikosana, Jeff Reeve, Katelynn S Madill-Thomsen, Philip F Halloran
BACKGROUND: The Banff system for histologic diagnosis of rejection in kidney transplant biopsies uses guidelines to assess designated features-lesions, donor-specific antibody (DSA), and C4d staining. We explored whether using regression equations to interpret the features as well as current guidelines could establish the relative importance of each feature and improve histologic interpretation. METHODS: We developed logistic regression equations using the designated features to predict antibody-mediated rejection (AMR/mixed) and T-cell-mediated rejection (TCMR/mixed) in 1679 indication biopsies from the INTERCOMEX study (ClinicalTrials...
September 20, 2023: Transplantation
keyword
keyword
160241
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.